SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

75,692.78 1,233.25
( 1.66%)

Global Indices

Nasdaq

51,732.40 -631.16
(-1.21%)

Dow Jones

7,581.68 -159.71
(-2.06%)

Hang Seng

63,112.86 -177.25
(-0.28%)

Nikkei 225

10,768.78 39.00
(0.36%)

Forex

USD-INR

95.22 0.06
(0.06%)

EUR-INR

106.19 0.24
(0.23%)

GBP-INR

127.01 0.44
(0.35%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

FDC Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

531599

INE258B01022

164.1526706

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

FDC

18.63

6132.24

EPS(TTM)

Face Value()

Div & Yield %

20.22

1.33

Back

corpus ltd

Procter & Gamble Health standalone net profit rises 45.29% in the June 2026 quarter

Aug 06,2026

Net profit of Procter & Gamble Health rose 45.29% to Rs 96.15 crore in the quarter ended June 2026 as against Rs 66.18 crore during the previous quarter ended June 2025. Sales rose 7.37% to Rs 363.71 crore in the quarter ended June 2026 as against Rs 338.74 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	363.71	338.74	7
OPM %	27.38	26.67	-
PBDT	103.34	94.25	10
PBT	97.32	88.81	10
NP	96.15	66.18	45

75,692.78 1,233.25 ( 1.66%)

51,732.40 -631.16 (-1.21%)

7,581.68 -159.71 (-2.06%)

63,112.86 -177.25 (-0.28%)

10,768.78 39.00 (0.36%)

95.22 0.06 (0.06%)

106.19 0.24 (0.23%)

127.01 0.44 (0.35%)

0.60 0.00 (0.12%)